RecruitingNCT07143669
Blood
Chronic mast cell leukemia
6
studies recruiting now
as of 7 Sept 2026
54
studies registered in total
as of 7 Sept 2026
14
countries with a recruiting site
as of 7 Sept 2026
27 Aug 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingNCT01137825
Registry of Older Patients With Cancer
RecruitingNCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingPhase 2NCT06355583
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 6 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Chronic mast cell leukemia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Chronic mast cell leukemia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (KIT).
Treatments being studied
14 approved treatments and 51 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Imatinib Mesylate (Gleevec)Approved: Omacetaxine Mepesuccinate (Synribo)Approved: Bosutinib Monohydrate (Bosulif)Approved: Hydroxyurea (Droxia)Approved: Interferon Alfa-N1 (Well-feron)Approved: Dasatinib (Dasatinib accord healthcare)Approved: NilotinibApproved: Nilotinib Hydrochloride Monohydrate (Tasigna)Approved: Busulfan (Busilvex)Approved: Asciminib Hydrochloride (Scemblix)Approved: Ponatinib Hydrochloride (Iclusig)Approved: AsciminibApproved: Dasatinib Anhydrous (Dasatinib accord)Approved: Imatinib
Phase 3Olverembatinib
Phase 3Cytarabine (Alexan)
Phase 3Cyclophosphamide (Cyclophosphamide)
Phase 3Sargramostim (Leukine)
Phase 3Interferon Alfa
Phase 3Bosutinib
Phase 3Peginterferon Alfa-2a (Pegasys)
Phase 3Ponatinib (Iclusig)
+ 43 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).